Delivery Order SPE2DB22D3401-SPE2DB25FT0LF

Award Date 10/30/24
Potential Completion Date 10/31/24
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Eliquis 5 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The $7,584.57 firm fixed price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 13, 2024. The contract has an ultimate completion date of November 14, 2024 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award is for the delivery of Eliquis 5 mg tablets to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The $4,150.64 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, on August 1, 2024, with an ultimate completion date of August 2, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award is for the delivery of Eliquis 5 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The $5,692.14 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract has an ultimate completion date of November 27, 2024 and was awarded on November 26, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This federal contract award is for the delivery of Eliquis 5 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The $7,600.32 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a period of performance through March 28, 2023. This appears to be a task order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through November...
This federal contract award is for the delivery of Eliquis 5 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The $38,960.77 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 4, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award is for the delivery of Eliquis 5 mg tablets to the Defense Logistics Agency (DLA). The $7,906.03 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 8, 2024 with a completion date of November 12, 2024. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range...
This federal contract award is for the delivery of Eliquis 5 mg tablets to the Defense Logistics Agency (DLA), a component of the Department of Defense. The contract, valued at $10,374.53, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price, with an ultimate completion date of August 14, 2024. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is the...
This federal contract award is for the delivery of Eliquis 2.5 mg tablets to the Defense Logistics Agency (DLA). The $2,494.42 Firm Fixed Price Delivery Order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on April 19, 2024, with a completion date of April 22, 2024. The contract is a part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products...
This federal contract award is for the delivery of Eliquis 5 mg tablets to the Defense Logistics Agency (DLA), a defense agency under the Department of Defense. The $25,644.17 firm-fixed-price delivery order contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 4, 2024, with a completion date of November 5, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of Eliquis 5 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The $10,330.69 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 9, 2024, with an ultimate completion date of August 12, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB22D3401
    Indefinite Delivery Contract
  • SPE2DB22D3401-SPE2DB25FT0LF
    Delivery Order

This federal contract award is for the delivery of Eliquis 5 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The $1,994.80 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, on October 30, 2024, with a completion date of October 31, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 1/29/25, 9:20 AM